{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:25:04Z","timestamp":1792686304524,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":64,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020989","name":"Gedeon Richter France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020989","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jogoh.2023.102664","type":"journal-article","created":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T09:54:53Z","timestamp":1693734893000},"page":"102664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Update on the management of endometriosis-associated pain in France"],"prefix":"10.1016","volume":"52","author":[{"given":"Herv\u00e9","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubert","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortense","family":"Baffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Chabbert-Buffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Estrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Giraudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Hocke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tremollieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Chapron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jogoh.2023.102664_bib0001","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41574-019-0245-z","article-title":"Rethinking mechanisms, diagnosis and management of endometriosis","volume":"15","author":"Chapron","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.jogoh.2023.102664_bib0002","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/humrep\/dew293","article-title":"World endometriosis society consensus on the classification of endometriosis","volume":"32","author":"Johnson","year":"2017","journal-title":"Hum Reprod"},{"issue":"13","key":"10.1016\/j.jogoh.2023.102664_bib0003","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMra1810764","volume":"382","author":"Zondervan","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jogoh.2023.102664_bib0004","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s12905-021-01545-5","article-title":"Treatment of endometriosis: a review with comparison of 8 guidelines","volume":"21","author":"Kalaitzopoulos","year":"2021","journal-title":"BMC Womens Health"},{"issue":"2","key":"10.1016\/j.jogoh.2023.102664_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoac009","article-title":"ESHRE guideline: endometriosis","volume":"2022","author":"Becker","year":"2022","journal-title":"Hum Reprod Open"},{"issue":"6","key":"10.1016\/j.jogoh.2023.102664_bib0006","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/1933719112438061","article-title":"The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis","volume":"19","author":"Chwalisz","year":"2012","journal-title":"Reprod Sci"},{"issue":"Suppl 10","key":"10.1016\/j.jogoh.2023.102664_bib0007","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1471-0528.1994.tb13677.x","article-title":"Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment","volume":"101","author":"Donnez","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.jogoh.2023.102664_bib0008","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/humrep\/deh250","article-title":"One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial","volume":"19","author":"Fernandez","year":"2004","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.jogoh.2023.102664_bib0009","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/AOG.0000000000003267","article-title":"Patterns of prescription opioid use in women with endometriosis: evaluating prolonged use, daily dose, and concomitant use with benzodiazepines","volume":"133","author":"Lamvu","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.jogoh.2023.102664_bib0010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12325-018-0667-3","article-title":"Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States","volume":"35","author":"Soliman","year":"2018","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.jogoh.2023.102664_bib0011","first-page":"267","article-title":"Medical treatment for the management of painful endometriosis without infertility: CNGOF-HAS Endometriosis Guidelines","volume":"46","author":"Sauvan","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"21","key":"10.1016\/j.jogoh.2023.102664_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111342","article-title":"GnRH antagonists with or without add-back therapy: a new alternative in the management of endometriosis?","volume":"22","author":"Donnez","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jogoh.2023.102664_bib0013","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.fertnstert.2017.05.004","article-title":"Reevaluating response and failure of medical treatment of endometriosis: a systematic review","volume":"108","author":"Becker","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2023.102664_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101263","article-title":"A new validated screening method for endometriosis diagnosis based on patient questionnaires","volume":"44","author":"Chapron","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.jogoh.2023.102664_bib0015","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.fertnstert.2021.07.1205","article-title":"Early identification of women with endometriosis by means of a simple patient-completed questionnaire screening tool: a diagnostic study","volume":"116","author":"Fauconnier","year":"2021","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.jogoh.2023.102664_bib0016","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41598-021-04637-2","article-title":"Machine learning algorithms as new screening approach for patients with endometriosis","volume":"12","author":"Bendifallah","year":"2022","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jogoh.2023.102664_bib0017","article-title":"Validation of a salivary miRNA signature of endometriosis \u2014 interim data","volume":"2","author":"Bendifallah","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2023.102664_bib0018","unstructured":"Statistiques) GGplEelRd. 2023;June."},{"issue":"1\u20132","key":"10.1016\/j.jogoh.2023.102664_bib0019","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.013","article-title":"Classification and pharmacology of progestins","volume":"61","author":"Schindler","year":"2008","journal-title":"Maturitas"},{"issue":"16","key":"10.1016\/j.jogoh.2023.102664_bib0020","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2165\/11206320-000000000-00000","article-title":"Dienogest: a review of its use in the treatment of endometriosis","volume":"70","author":"McCormack","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.jogoh.2023.102664_bib0021","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/IJWH.S5633","article-title":"Dienogest in long-term treatment of endometriosis","volume":"3","author":"Schindler","year":"2011","journal-title":"Int J Womens Health"},{"issue":"11","key":"10.1016\/j.jogoh.2023.102664_bib0022","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1177\/0091270011423664","article-title":"Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women","volume":"52","author":"Klipping","year":"2012","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jogoh.2023.102664_bib0023","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.fertnstert.2007.12.080","article-title":"Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis\u2013a randomized, double-blind, multicenter, controlled trial","volume":"91","author":"Harada","year":"2009","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.jogoh.2023.102664_bib0024","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/humrep\/dep469","article-title":"Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial","volume":"25","author":"Strowitzki","year":"2010","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.jogoh.2023.102664_bib0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12905-022-01737-7","article-title":"Randomized study on the effectiveness of nomegestrol acetate plus 17beta-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis\u2011associated chronic pelvic pain","volume":"22","author":"Caruso","year":"2022","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.jogoh.2023.102664_bib0026","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejogrb.2021.10.029","article-title":"Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: randomized clinical trial","volume":"267","author":"El Taha","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.jogoh.2023.102664_bib0027","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/09513590.2021.1892632","article-title":"Dienogest versus continuous oral levonorgestrel\/EE in patients with endometriosis: what's the best choice?","volume":"37","author":"Piacenti","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jogoh.2023.102664_bib0028","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.2147\/JPR.S207599","article-title":"Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain","volume":"12","author":"Caruso","year":"2019","journal-title":"J Pain Res"},{"issue":"4","key":"10.1016\/j.jogoh.2023.102664_bib0029","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s43032-021-00787-w","article-title":"Impact of long-term dienogest therapy on quality of life in asian women with endometriosis: the prospective non-interventional study ENVISIOeN","volume":"29","author":"Techatraisak","year":"2022","journal-title":"Reprod Sci"},{"issue":"5","key":"10.1016\/j.jogoh.2023.102664_bib0030","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jpag.2017.01.014","article-title":"Dienogest 2mg daily in the treatment of adolescents with clinically suspected endometriosis: the visanne study to assess safety in adolescents","volume":"30","author":"Ebert","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"10.1016\/j.jogoh.2023.102664_bib0031","first-page":"e36729","article-title":"Efficacy of dienogest in adolescent endometriosis: a narrative review","volume":"15","author":"Tayade","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jogoh.2023.102664_bib0032","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/09513590.2019.1640674","article-title":"Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study","volume":"36","author":"Angioni","year":"2020","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"10.1016\/j.jogoh.2023.102664_bib0033","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1080\/01443615.2020.1867962","article-title":"Dienogest reduces endometrioma volume and endometriosis-related pain symptoms","volume":"41","author":"Uludag","year":"2021","journal-title":"J Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.jogoh.2023.102664_bib0034","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/09513590.2020.1725965","article-title":"Effect of Dienogest therapy on the size of the endometrioma","volume":"36","author":"Vignali","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jogoh.2023.102664_bib0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejogrb.2017.02.015","article-title":"Dienogest and deep infiltrating endometriosis: the remission of symptoms is not related to endometriosis nodule remission","volume":"211","author":"Leonardo-Pinto","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2023.102664_bib0036","doi-asserted-by":"crossref","DOI":"10.1007\/s43032-023-01266-0","article-title":"The efficacy of dienogest in reducing disease and pain recurrence after endometriosis surgery: a systematic review and meta-analysis","author":"Muzii","year":"2023","journal-title":"Reprod Sci"},{"issue":"7","key":"10.1016\/j.jogoh.2023.102664_bib0037","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jmig.2020.05.007","article-title":"Dienogest and the risk of endometriosis recurrence following surgery: a systematic review and meta-analysis","volume":"27","author":"Zakhari","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jogoh.2023.102664_bib0038","article-title":"Dienogest as a maintenance treatment for endometriosis following surgery: a systematic review and meta-analysis","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jogoh.2023.102664_bib0039","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2147\/IJWH.S77202","article-title":"Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program","volume":"7","author":"Strowitzki","year":"2015","journal-title":"Int J Womens Health"},{"issue":"1","key":"10.1016\/j.jogoh.2023.102664_bib0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5468\/ogs.2018.61.1.111","article-title":"Clinical experience of long-term use of dienogest after surgery for ovarian endometrioma","volume":"61","author":"Chandra","year":"2018","journal-title":"Obstet Gynecol Sci"},{"issue":"4","key":"10.1016\/j.jogoh.2023.102664_bib0041","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00404-018-4864-8","article-title":"Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice","volume":"298","author":"Romer","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.jogoh.2023.102664_bib0042","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejogrb.2011.03.012","article-title":"Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain","volume":"157","author":"Kitawaki","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.jogoh.2023.102664_bib0043","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/03007995.2020.1744120","article-title":"Use of dienogest in endometriosis: a narrative literature review and expert commentary","volume":"36","author":"Murji","year":"2020","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.jogoh.2023.102664_bib0044","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.fertnstert.2022.08.856","article-title":"Oral gonadotropin-releasing hormone antagonists for treating endometriosis-associated pain: a systematic review and network meta-analysis","volume":"118","author":"Yan","year":"2022","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.jogoh.2023.102664_bib0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa1700089","article-title":"Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist","volume":"377","author":"Taylor","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2023.102664_bib0046","unstructured":"AbbVie. Orilissa (elagolix tablets) prescribing information. https:\/\/www.rxabbvie.com\/pdf\/orilissa_pi.pdf. 2023."},{"issue":"14","key":"10.1016\/j.jogoh.2023.102664_bib0047","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s40265-018-0977-4","article-title":"Elagolix: first global approval","volume":"78","author":"Lamb","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jogoh.2023.102664_bib0048","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/DDDT.S269976","article-title":"Profile of linzagolix in the management of endometriosis, including design, development and potential place in therapy: a narrative review","volume":"17","author":"Donnez","year":"2023","journal-title":"Drug Des Devel Ther."},{"issue":"1","key":"10.1016\/j.jogoh.2023.102664_bib0049","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.fertnstert.2020.02.114","article-title":"Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial","volume":"114","author":"Donnez","year":"2020","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.jogoh.2023.102664_bib0050","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s40265-022-01753-9","article-title":"Linzagolix: first approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jogoh.2023.102664_bib0051","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12905-021-01393-3","article-title":"Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results","volume":"21","author":"Osuga","year":"2021","journal-title":"BMC Womens Health"},{"issue":"3","key":"10.1016\/j.jogoh.2023.102664_bib0052","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.fertnstert.2021.11.013","article-title":"an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study","volume":"117","author":"Harada","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogoh.2023.102664_bib0053","unstructured":"Myovant Sciences. Myfembree (relugolix, estradiol, and norethindrone acetate) tablets prescribing information. https:\/\/www.myovant.com\/wp-content\/uploads\/2023\/01\/Approved-MYFEMBREE-PI-and-PPI_27January2023.pdf. 2023."},{"issue":"1","key":"10.1016\/j.jogoh.2023.102664_bib0054","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/17.1.221","article-title":"Determinants of early follicular phase gonadotrophin and estradiol concentrations in women of late reproductive age","volume":"17","author":"Cramer","year":"2002","journal-title":"Hum Reprod"},{"issue":"10343","key":"10.1016\/j.jogoh.2023.102664_bib0055","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(22)00622-5","article-title":"Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)","volume":"399","author":"Giudice","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jogoh.2023.102664_bib0056","first-page":"36","article-title":"O-132 Sustained efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT 52-week data","author":"As-Sanie","year":"2021","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.jogoh.2023.102664_bib0057","article-title":"Combination GnRH antagonists for endometriosis: balancing efficacy with side effects","volume":"3","author":"Whitaker","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jogoh.2023.102664_bib0058","doi-asserted-by":"crossref","unstructured":"As-Sanie S.M.G., Linda M.D.; Imm, So Jung MS; Johnson, Neil MD; Mehedintu, Claudia BS; Perry, Julie MD.. Bleeding Patterns With Relugolix Combination Therapy in Women With Endometriosis-Associated Pain [ID: 1345374]. 141(5S):p 12S, May Obstet Gynecol. 2023.","DOI":"10.1097\/01.AOG.0000929844.43483.20"},{"key":"10.1016\/j.jogoh.2023.102664_bib0059","unstructured":"Ryeqo (relugolix 40mg, estradiol 1\u00b70mg, and norethisterone acetate 0\u00b75mg) \u2013 summary of products characteristics. July 20, 2021. https:\/\/ec.europa.eu\/health\/documents\/community-register\/2021\/20210716152087\/anx_152087_en.pdf (accessed Aug 22, 2021). 2021."},{"key":"10.1016\/j.jogoh.2023.102664_bib0060","unstructured":"Press release October 25, 2022 https:\/\/www.gedeonrichter.com\/en\/news\/221025."}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784723001319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784723001319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:03:42Z","timestamp":1762855422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784723001319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2468784723001319"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2023.102664","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the management of endometriosis-associated pain in France","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2023.102664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102664"}}